2RT spending is kept at a minimum until a partner is found to fund the big trial. The last 2 capital raises mandate was to fund the growth and expansion of iTrack. Raised funds is not used for 2RT.
EYE Summary (August 2024): Incredibly Undervalued, page-106
-
- There are more pages in this discussion • 271 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.5¢ |
Change
-0.005(2.63%) |
Mkt cap ! $42.37M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 19.5¢ | 18.5¢ | $44.75K | 237.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 51300 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 26719 | 1 |
View Market Depth
| Last trade - 16.10pm 21/10/2024 (20 minute delay) ? |
| EYE (ASX) Chart |